Confidentiality and MAT

Pre-Conference Speaker(s)

  • Paul Samuels, JD

    Director/President
    Legal Action Center

  • Christine Khaikin, JD

    Legal Action Center

  • Caroline Waterman, LRC, MA,CRC

    Director Substance Use Disorders Training and TA
    CAI (Cicatelli Associates Inc)

The Center of Excellence for Protected Health Information

Funded by SAMHSA, the Center of Excellence for Protected Health Information (CoE-PHI) develops and disseminates resources, training, and TA for states, healthcare providers, school administrators and individuals and families to improve understanding and application of federal privacy laws and regulations, including FERPA, HIPAA, and 42 CFR Part 2, when providing and receiving treatment for SUD and mental illness.

There is often confusion about the ways in which 42 CFR Part 2 (“Part 2”), the regulations protecting the confidentiality of substance use disorder, applies to medication-assisted treatment (MAT) providers. Many buprenorphine and naltrexone providers are not subject to Part 2 at all. This training will provide an overview of the applicability of Part 2 in different MAT settings, including emergency departments and primary care practices. It will review the general requirements of Part 2 and explain issues such as how MAT providers may interact with prescription drug monitoring programs and how may they communicate with patients’ families after an overdose. It will also introduce the SAMHSA Center of Excellence for Protected Health Information.

Learning Objectives:

  • Describe key components of the Federal confidentiality regulations, 42 CFR Part 2, recent updates, and proposed updates.
  • Describe special issues for OTPs and MAT prescribers under Part 2
  • Describe SAMHSA Center of Excellence for Protected Health Information

Like too many New Yorkers, I know what it's like to lose a loved one to addiction—there’s an empty chair at our family table where my nephew, Michael, should be. This is personal for me. Today we’re taking action to combat the opioid epidemic and offer New Yorkers hope. Thread⬇️

Load More...

#aatod2022 conference

AATOD, Inc.
225 Varick Street, Suite 402
New York, New York 10014

Contact Us
Phone : 212-566-5555
Email : info@aatod.org

Social Sharing
RSS
Follow by Email
Facebook
Twitter
YouTube
LinkedIn
Instagram

Stay Connected to AATOD